130P Ipilimumab plus nivolumab (Ipi+Nivo) in patients with tumors harboring high tumor mutational burden or load (TMB/TML-H): Results from the Drug Rediscovery Protocol (DRUP) von Mohammad, S.F. Haj, Verkerk, K., Zeverijn, L.J., Geurts, B.S., Spiekman, I.A.C., Verbeek, F., Roepman, P., Jansen, A., de Leng, W., Robbrecht, D., Marchetti, S., Verheul, H.M.W., Voest, E.E., Gelderblom, H.

Volltext

197P PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trials von Kringelbach, T.M., Fagereng, L., Mohammad, S.F. Haj, Verbeek, F., Timmer, H.J.L., Juslin, T., Verlingue, L., Krebs, M.G., Blay, J-Y., Jalkanen, K., Rohrberg, K.S., Lassen, U.N., Helland, A., Verheul, H.M.W., Voest, E.E., Gelderblom, H., Tasken, K.

Volltext

1711P The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine von Gelderblom, H., Edsjö, A., Russnes, H.E.G., Lassen, U.N., Helland, A., Hallersjö Hult, E., Ryll, B., Lugowska, I., Blay, J-Y., Falk, R.S., van Waalwijk van Doorn-Khosrovani, S., Steen Carlsson, K., Peltola, K., Stenzinger, A., Vrdoljak, E., Oliveira, J., Haj Mohammad, S.F., Verheul, H.M.W., Voest, E.E., Tasken, K.

Volltext